Eshallgo【EHGO】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Eshallgo Inc (EHGO) 銘柄情報

Eshallgo Inc (EHGO)

1.0919

-0.0081

( -0.74% )

更新日時： 00:59:07

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.0919

買値

1.10

売値

1.12

出来高

18,728

1.06 日の範囲 1.1009

0.91 52 週間の範囲 5.498

前日終値

1.10

始値

1.06

時刻

最終取引時間

00:59:06

平均取引量 (3 か月)

446,248

財務取引量

US$ 20,540

VWAP

1.0968

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 424B2 - Prospectus [Rule 424(b)(2)]

EHGO and Zhenjiang High-tech Zone to Jointly Build an AI Data Center and Supply Chain Center for Office Solutions

EHGO and Zhenjiang High-tech Zone to Jointly Build an AI Data Center and Supply Chain Center for Office Solutions PR Newswire SHANGHAI, Jan. 13...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

Form D/A - Notice of Exempt Offering of Securities: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.0019	0.174311926606	1.09	1.12	1.06	48219	1.08222345	CS
4	-0.0081	-0.736363636364	1.1	1.16	1	70770	1.08489281	CS
12	-2.9681	-73.10591133	4.06	5.498	0.91	446248	2.72842367	CS
26	-0.7881	-41.920212766	1.88	5.498	0.91	202879	2.74267587	CS
52	-2.9081	-72.7025	4	5.498	0.91	177115	2.70064874	CS
156	-2.9081	-72.7025	4	5.498	0.91	177115	2.70064874	CS
260	-2.9081	-72.7025	4	5.498	0.91	177115	2.70064874	CS

EHGO - Frequently Asked Questions (FAQ)

What is the current Eshallgo share price?

The current share price of Eshallgo is US$ 1.0919

What is the 1 year trading range for Eshallgo share price?

Eshallgo has traded in the range of US$ 0.91 to US$ 5.498 during the past year

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
KWEKWESST Micro Systems Inc	US$ 0.8982 (92.33%)	168.96M
PRPHProPhase Labs Inc	US$ 0.5286 (62.65%)	119.28M
ALLOAllogene Therapeutics Inc	US$ 3.22 (57.84%)	42M
STAIScanTech AI Systems Inc	US$ 3.155 (53.90%)	43M
SLDBSolid Biosciences Inc	US$ 6.00 (48.88%)	48.74M
SEPNSepterna Inc	US$ 4.61 (-64.43%)	3.02M
INLFINLIF Limited	US$ 6.75 (-58.67%)	1.26M
BPTHBio Path Holdings Inc	US$ 0.27 (-57.36%)	2.89M
RSLSReShape Lifesciences Inc	US$ 1.115 (-52.15%)	3.84M
PTPIPetros Pharmaceuticals Inc	US$ 0.1431 (-51.16%)	16.04M
ADTXAditxt Inc	US$ 0.07985 (14.07%)	275.95M
KWEKWESST Micro Systems Inc	US$ 0.8982 (92.33%)	169.17M
PRPHProPhase Labs Inc	US$ 0.5286 (62.65%)	119.75M
INTCIntel Corporation	US$ 25.8135 (9.38%)	83.4M
NVDANVIDIA Corporation	US$ 140.17 (0.95%)	69.91M

ChannelTrader

ChannelTrader 2分前

Steve Bannon Live on Rav TV...heating up big time ... https://americasvoice.news/

TheRealMrPirate

TheRealMrPirate 2分前

for the love on Bioamber and our shares
Ah, about that.
There are no longer shares here, no longer a corporation here.

cojoboy

cojoboy 2分前

Wish I had bought more of those 48's.🤔🤔🤔🤔

Myth

Rock Me · Steppenwolf

https://www.youtube.com/watch?v=boo0XLeCpVg

Doc logic

Doc logic 2分前

improving,

That might not be a good idea for him to follow up on if his clients include a consortium of 7 market makers and or hedge funds with them; ). Best wishes.

pitcook

pitcook 3分前

If only an idiotic paid hyper could post 5 times today about some meaninless awards, I'm sure the stock will rocket up beause that would make it DEAL TIME!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Monroe1

Monroe1 3分前

How many heads will roll? Plenty but not enough IMO. CytoDyn will benefit from a fairer playing field.
https://www.fiercehealthcare.com/regulatory/mass-layoffs-hhs-cdc-cuts-1300-probationary-workers-reports-say?oly_enc_id=4924G0643390I0A

work-n-hard

work-n-hard 3分前

I would bet, multiple times.

cojoboy

cojoboy 3分前

We known that was coming for a long time...

TightCoil

TightCoil 3分前

Big Guns are letting us Retails play around,, creating doubt, waiting like
vultures for just the right time to put more of these diamonds in their stash

HOLD - HOLD - HOLD

eastunder

eastunder 4分前

MU cpps 105.23

Orig Plan: CP on Repos when green

A:106.55/ 87.06 600 (100cp) 500
S: H4Quantity/ 500
Tr: 106.35 /86.67 525 (25cp) 500
T: 103.08/88.03 400 (150cp) 250
JP: 104.36/86.64 1400 (400cp) 1000
Ab:106.61/86.74 575 (75cp) 500

duderaja

duderaja 4分前

Nice day here at STAI and this is just the beginning.

PENNIEStoSTACKS

PENNIEStoSTACKS 4分前

https://x.com/PENNIEStoSTACKS/status/1891883341596529131

Truthsocial

Truthsocial 4分前

Totally agree with your comment I have been here a long time with vivos I just haven't been on this broken record board long. But it's criminal negligence by the FDA and I know this will hackle some sensitive feathers protecting their corrupt system but I say to them foff.

RDGL

MahinAgency

MahinAgency 4分前

NASDAQ: $TLSA Big Opportunity⚡️

BREAKING NEWS🎯

'Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program'

Helloman1

Helloman1 4分前

Trips will be gone very soon imo.

Helloman1

Helloman1 4分前

Trips will be gone very soon imo.

tigerpac

tigerpac 4分前

Took the money and ran on the dead cat bounce. Out at 11.80 for an 8% daily gain.

Likely will revisit later.

cadillacdave

cadillacdave 4分前

You seem to have a very one dimensional view point here.Anyone who doesn't march in lockstep with your viewpoints is spreading FUD or short. I am neither.

If you care to read any of my prior posts, I point out much of the upside here, the many patents that are held, leader in the fiel

gotinearly

gotinearly 4分前

I bet he was vaxxed

Golden Cross

Golden Cross 4分前

Nice buy volume so far...$TLSA

jog49

"The GSEs are expected to hit those requirements by the end of 2026....without a capital infusion proposed by the likes of Ackmann. So, do we really need even his proposal?"

Nope. He's a hedge fund manager, has set a target for his clients of $26-43 or whatever that range was, and wil

arizona1

arizona1 5分前

https://bsky.app/profile/georgetakei.bsky.social/post/3lhrmhdu6ys2u

AyaStocks

AyaStocks 5分前

$ADIA Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products https://www.otcmarkets.com/stock/ADIA/news/Adia-Med-Partners-with-Premier-FDA-Approved-Lab-for-High-Quality-Umbilical-Cord-Stem-Cell-and-Exosome-Products?id=467906

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約